Teva to Present at the 2013 RBC Capital Markets Global Healthcare Conference
RBC Capital Markets Global Healthcare Conference 2013
JERUSALEM -- February 25, 2013
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) will host a live audio
webcast at the 2013 RBC Capital Markets Global Healthcare Conference. Jon
Congleton, SVP, Global Medicines Group, will present on Wednesday, February
What: Teva Presentation at the 2013 RBC Capital Markets Global Healthcare
Who: Jon Congleton, SVP, Global Medicines Group
When: Wednesday, February 27 2013 at 1:30 PM (EST)
Where: www.tevapharm.com or
How: Live over the Internet – log on to the Web at the address above and
register for the
event (approximately 10 minutes before). An archive of the webcast
will be available
on Teva’s website.
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) is a leading global
pharmaceutical company, committed to increasing access to high-quality
healthcare by developing, producing and marketing affordable generic drugs as
well as innovative and specialty pharmaceuticals and active pharmaceutical
ingredients. Headquartered in Israel, Teva is the world's leading generic drug
maker, with a global product portfolio of more than 1,000 molecules and a
direct presence in about 60 countries. Teva's branded businesses focus on CNS,
oncology, pain, respiratory and women's health therapeutic areas as well as
biologics. Teva currently employs approximately 46,000 people around the world
and reached $20.3 billion in net revenues in 2012.
Teva Pharmaceutical Industries Ltd.
Kevin C. Mannix
972 (3) 926-7656
972 (3) 926-7687
Press spacebar to pause and continue. Press esc to stop.